Mackenzie Financial
ARIA

Mackenzie Financial’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Mackenzie Financial’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-113,737
Closed -$841K – 934
2016
Q2 		$841K Buy
+113,737
New +$853K ﹤0.01% 644

Other funds holding ARIA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Mackenzie Financial's ARIA Position: Q3 2016 in Review

Mackenzie Financial sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2016, closing a stake of 113,737 shares — an estimated $841K sold.

Mackenzie Financial first reported a position in ARIA in Q2 2016 and held it in 1 quarter. The position peaked at $841K in Q2 2016. 202 funds tracked by Wall St. Rank hold ARIA as of Q3 2016.

  • Mackenzie Financial reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2016 after selling out during the quarter.
  • Mackenzie Financial sold 113,737 Ariad Pharmaceuticals Inc shares in Q3 2016, an estimated $841K.
  • Mackenzie Financial first reported a position in Ariad Pharmaceuticals Inc in Q2 2016 and held it in 1 quarter.
  • Mackenzie Financial's Ariad Pharmaceuticals Inc position peaked at $841K in Q2 2016.
  • 202 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2016.

Based on Mackenzie Financial's 13F filing for Q3 2016, filed 15 Nov 2016.